S
26.77
0.39 (1.48%)
| 前收盘价格 | 26.38 |
| 收盘价格 | 24.84 |
| 成交量 | 9,355 |
| 平均成交量 (3个月) | 318,150 |
| 市值 | 1,198,605,184 |
| 预期市盈率 (P/E Forward) | 104.17 |
| 价格/销量 (P/S) | 52.79 |
| 股市价格/股市净资产 (P/B) | 3.00 |
| 52周波幅 | |
| 利润日期 | 10 Nov 2025 |
| 营业利益率 (TTM) | -11,831.05% |
| 稀释每股收益 (EPS TTM) | -1.78 |
| 季度收入增长率 (YOY) | -30.90% |
| 总债务/股东权益 (D/E MRQ) | 6.25% |
| 流动比率 (MRQ) | 32.19 |
| 营业现金流 (OCF TTM) | -74.10 M |
| 杠杆自由现金流 (LFCF TTM) | -25.69 M |
| 资产报酬率 (ROA TTM) | -17.20% |
| 股东权益报酬率 (ROE TTM) | -30.96% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看涨 | 混合的 |
| Biotechnology (全球的) | 看涨 | 混合的 | |
| 股票 | Septerna, Inc. | 看涨 | 看跌 |
AIStockmoo 评分
0.8
| 分析师共识 | 4.0 |
| 内部交易活动 | NA |
| 价格波动 | -0.5 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -0.5 |
| 平均 | 0.75 |
|
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, and GLP-1R, GIPR, GCGR. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 内部持股比例 | 2.64% |
| 机构持股比例 | 105.46% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Trv Gp V, Llc | 30 Sep 2025 | 6,215,591 |
| Trv Gp Vi, Llc | 30 Sep 2025 | 4,211,659 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 43.00 (Jones Trading, 60.63%) | 购买 |
| 中 | 34.00 (27.01%) | |
| 低 | 28.00 (Wells Fargo, 4.60%) | 购买 |
| 平均值 | 34.60 (29.25%) | |
| 总计 | 5 购买 | |
| 平均价格@调整类型 | 25.50 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Jones Trading | 23 Dec 2025 | 43.00 (60.63%) | 购买 | 28.23 |
| Raymond James | 19 Dec 2025 | 38.00 (41.95%) | 购买 | 29.58 |
| Truist Securities | 15 Dec 2025 | 34.00 (27.01%) | 购买 | 27.18 |
| Wells Fargo | 14 Nov 2025 | 28.00 (4.59%) | 购买 | 23.27 |
| HC Wainwright & Co. | 11 Nov 2025 | 30.00 (12.07%) | 购买 | 19.24 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合